Subscribe to MDT Magazine News

Reportlinker Adds Global Hematology Instruments and Reagents Industry

February 23, 2011 2:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- announces that a new market research report is available in its catalogue: Global Hematology Instruments and Reagents Industry This report analyzes the...


WellPoint board declares initial 25-cent dividend

February 23, 2011 1:45 am | by The Associated Press | Comments

WellPoint says its board of directors declared an initial dividend of 25 cents, citing its capital position a month after topping Wall Street's earnings expectations and becoming the latest health insurer to make increase its payout.Big health insurers normally offer token dividends like the...

JK Lasers Set To Participate In Medtec UK 2011

February 23, 2011 1:35 am | by RealWire | Comments

Laser Manufacturer to Promote Benefits of Lasers for Medical Device Processing Industrial laser manufacturer, JK Lasers (part of the GSI Group), will be participating in this year's Medtec UK exhibition, part of a series of events designed specifically for the medical device manufacturing...


NHS Hearing Aids - Free But at What Price?

February 23, 2011 12:34 am | by Bio-Medicine.Org | Comments

PRESTON, England, Feb. 23, 2011 /- In the UK we are fortunate enough to have a free provision of hearing aids by way of the NHS. Over the last few years, the NHS has switched from analogue to digital hearing aids for the majority of patients. These hearing instruments are of a reasonable...


Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials

February 22, 2011 11:36 pm | by Bio-Medicine.Org | Comments

LONDON, Feb. 23, 2011 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office (USPTO).  The issued patent, which represents a...


High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIOâ„¢ Phase II Study Reported in American Journal of Clinical Oncology

February 22, 2011 11:35 pm | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 23, 2011 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the...


Quanterix, Novartis sign biomarker deal

February 22, 2011 11:34 pm | by Mass High Tech: The Journal of New England Technology | Comments

Diagnostics company Quanterix Corp. today announced an evaluation agreement with Novartis Diagnostics under which the unit of Novartis AG will look at the potential use of Quanterix's technology on a neuron-specific protein target.


Lower Risk of False Positive With Digital Mammography

February 22, 2011 11:34 pm | by Diagnostic Imaging | Comments

HealthDay News - Traditional screen-film more likely leads to unneeded invasive procedures than digital method


Preoperative MRI Detects Spinal Injuries

February 22, 2011 11:33 pm | by Diagnostic Imaging | Comments

HealthDay News - Signs of spinal cord injury on MRI give indication of neurological prognosis after surgery


SiTime raises the bar on frequency stability of timing components

February 22, 2011 8:36 pm | by I-Micronews | Comments

First to Offer 25 PPM Total Frequency Stability for the Same Price as 50-100 PPM.

Chip-to-Wafer direct-metallic-bonding technology developed at Leti used in customized 300mm device bonder

February 22, 2011 8:36 pm | by I-Micronews | Comments

CEA-Leti Partnering with SET, STMicroelectronics, ALES and CNRS-CEMES On Advanced Chip-to-Wafer Technologies for 3D Integration.

Bosch acceleration sensors for chassis control

February 22, 2011 8:36 pm | by I-Micronews | Comments

World?s first low-g sensors with PSI5 interface.

Affymetrix says Paul Berg retiring from board

February 22, 2011 1:45 pm | by The Associated Press | Comments

Genetic testing instrument maker Affymetrix Inc. said Tuesday that Paul Berg will retire from its board of directors in May.Berg, 84, has been a member of Affymetrix's board since the company was founded in 1993. Berg was one of the recipients of the Nobel Prize in Chemistry in 1980 for his...

Cancer-causing virus exploits key cell-survival proteins

February 22, 2011 12:37 pm | by EurekAlert | Comments

(Ohio State University Medical Center) The human T-lymphotropic virus type 1, a cancer-causing retrovirus, exploits key proteins in host cells to extend the life of those cells, thereby prolonging its own survival and ability to spread, according to a new study. The virus, which...


Amedisys sees 42 percent profit drop

February 22, 2011 11:45 am | by The Associated Press | Comments

Home health provider Amedisys Inc. said Tuesday its profit dropped 42 percent in the fourth quarter as revenue fell slightly in the face of rising costs.For the October-through-December period, Baton Rouge-based Amedisys earned $22.1 million, or 77 cents per share, compared with year-ago...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.